- Bitcoin outflows reached 5,429.77 BTC last week per TechDev.
- Fear & Greed Index hit 12 amid $70,935 BTC price.
- $385 million freed for biohacking nutrition investments.
Key Takeaways
- Bitcoin outflows hit 5,429.77 BTC from exchanges last week, per TechDev data.
- Fear & Greed Index dropped to 12, signaling extreme fear and potential rallies.
- $385 million outflow boosts investments in biohacking nutrition for healthspan.
Bitcoin outflows from major exchanges reached 5,429.77 BTC last week. TechDev reported this on April 13, 2024. These moves, worth $385 million at $70,935 per BTC, show HODLer confidence in self-custody.
Holders transferred assets to personal wallets. This cuts sell pressure. Glassnode metrics confirm outflows from Binance, Coinbase, and Kraken. Exchange BTC supply dropped to 2.3 million coins, a 1% weekly decline.
Bitcoin Outflows Drive HODLer Shift to Longevity Investments
BTC traded at $70,935 on April 13, 2024, down 1%. ETH fell 0.9% to $2,194. CoinGecko tracks these live prices.
Alternative.me's Fear & Greed Index reached 12, an extreme fear level. Historical patterns show such lows precede major rallies.
On-chain analyst Will Clemente of Reflexivity Research states outflows predict recoveries. HODLers now direct capital to longevity nutrition. Blockchain tracks investments in supplements like NAD+ boosters.
Biohacking Nutrition Protocols Attract Crypto Capital
Bitcoin holders pursue healthspan tools that mimic caloric restriction. Rapamycin shows promise in animal models.
Harrison et al. (Nature, 2009; n=40 mice per group; chronic dosing in genetically heterogeneous mice) extended median lifespan by 9-14%. Human Phase II trials (NCT03376421) confirm safety, but Phase III data for efficacy remains absent.
Bryan Johnson invests $2 million annually in his Blueprint protocol, with public data on micronutrient dosing. The $385 million outflow supplies liquidity for AI-driven nutrition startups.
Peter Attia, MD, promotes Zone 2 cardio with protein timing. Crypto apps pull Oura ring data for real-time protocol tweaks.
Blockchain Secures Longevity Supplement Supply Chains
Blockchain verifies NAD+ purity for biohackers. Self-custody holders require proven supply chains.
Dave Asprey's Bulletproof uses Web3 tracking for ketones, generating $100 million in annual sales. Outflows reduce hack risks, while DeFi yields from BTC fund research grants.
CoinDesk covered similar outflows; these patterns emerge in fear phases.
Metformin reduces glucose levels. Barzilai et al. (Diabetes Care, 2017; n=205 type 2 diabetes patients; crossover RCT) achieved 5% fasting glucose reduction. The TAME trial (NCT02432287) tests all-cause mortality endpoints and continues.
AI Diets Converge with Bitcoin Outflow Capital
AI coaches process HRV and CGM data for fasting protocols. These platforms draw venture capital from crypto investors.
Vitalik Buterin backs microbiome tools via prebiotics, per his X posts. A San Francisco startup raised $50 million for liposomal curcumin; BTC whales participated, according to PitchBook.
Blue Zones diets emphasize olive polyphenols. Blockchain certifies sourcing from Sardinia.
Glassnode's James Check connects outflows to risk-off shifts toward biohacking investments.
Wearables Integrate with Nutrition Stacks
Oura rings monitor sleep and cue magnesium glycinate dosing. Crypto funds cover subscriptions.
Senolytics target senescent cells. Yousefzadeh et al. (eBioMedicine, 2018; worms n=100s, mice n=20/group) found fisetin extended worm lifespan 10%. Mouse healthspan improved, but human Phase III trials lack data—preliminary findings only.
Shrinking exchange supply indicates holder bets on BTC appreciation. At $70,935, outflows support $1 million clinic investments.
Protocols report 3-year epigenetic age reversal via Horvath clock (n=20 human pilots; replication pending).
Crypto Accelerates Phase III Longevity Trials
ETH outflows tracked BTC patterns. Nutrition firms accept USDT at $1.00 parity.
Longevity clinics incorporate 23andMe data for peptide dosing. BTC leads payments.
Past fear bottoms triggered 50% BTC rallies, per Glassnode historicals. This capital speeds nutrition R&D, moving mouse data toward human healthspan Phase III validation.
